A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Zepp Health Corp
ZEPP
$1.2B
Mkt Cap
$4.95
-1.00%
Business description not available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 259M | 259M | 183M | 2.5B | 4.1B | 6.3B |
| Net Income | -40M | -40M | -76M | -31M | -43M | 22M |
| EPS | $-0.16 | $-0.16 | $-0.29 | $-0.13 | $-0.18 | $0.08 |
| Free Cash Flow | -26M | -26M | -26M | 41M | -118M | -44M |
| ROIC | -5.8% | -13.3% | -19.0% | -6.5% | -8.2% | 2.9% |
| Gross Margin | 38.3% | 38.3% | 38.5% | 3.7% | 2.9% | 3.3% |
| Debt/Equity | 1.11 | 1.11 | 0.60 | 0.71 | 0.87 | 0.92 |
| Dividends/Share | $0.00 | - | - | - | $0.03 | - |
| Operating Income | -29M | -29M | -47M | -30M | -62M | 15M |
| Operating Margin | -11.3% | -11.3% | -25.9% | -1.2% | -1.5% | 0.2% |
| ROE | -18.7% | -17.2% | -25.1% | -8.4% | -10.2% | 4.9% |
| Shares Outstanding | 250M | 250M | 261M | 239M | 240M | 270M |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 896M | 1.6B | 2.0B | 3.6B | 5.8B | 6.4B | 6.3B | 4.1B | 2.5B | 183M | 259M | 259M |
| Gross Margin | 12.3% | 17.7% | 3.7% | 3.7% | 3.6% | 3.2% | 3.3% | 2.9% | 3.7% | 38.5% | 38.3% | 38.3% |
| R&D | 62M | 132M | 24M | 38M | 62M | 82M | 81M | 77M | 52M | 46M | 45M | 45M |
| SG&A | 70M | 103M | 18M | 31M | 36M | 40M | 41M | 35M | 27M | 25M | 29M | 29M |
| EBIT | -40M | 13M | 28M | 53M | 87M | 27M | 15M | -62M | -30M | -47M | -29M | -29M |
| Op. Margin | -4.5% | 0.9% | 1.4% | 1.5% | 1.5% | 0.4% | 0.2% | -1.5% | -1.2% | -25.9% | -11.3% | -11.3% |
| Net Income | -61M | -12M | 26M | 17M | 82M | 35M | 22M | -43M | -31M | -76M | -40M | -40M |
| Net Margin | -6.8% | -0.8% | 1.3% | 0.5% | 1.4% | 0.5% | 0.3% | -1.0% | -1.2% | -41.5% | -15.5% | -15.5% |
| Non-Recurring | 0 | 0 | -30K | -4K | -110K | -1.1M | 48K | 284K | -53K | 56K | -21K | -21K |
| Returns on Capital | ||||||||||||
| ROIC | N/A | 1.1% | 10.7% | 67.5% | 54.0% | 7.2% | 2.9% | -8.2% | -6.5% | -19.0% | -13.3% | -5.8% |
| ROE | 444.7% | -264.8% | 79.4% | 11.1% | 26.4% | 9.0% | 4.9% | -10.2% | -8.4% | -25.1% | -17.2% | -18.7% |
| ROA | N/A | -2.5% | 4.3% | 4.7% | 13.5% | 4.3% | 2.3% | -5.0% | -4.4% | -13.0% | -7.3% | -7.1% |
| Cash Flow | ||||||||||||
| Op. Cash Flow | -6.8M | 17M | 37M | 103M | 61M | 24M | -36M | -117M | 43M | -24M | -26M | -26M |
| Free Cash Flow | -9.7M | 7.0M | 33M | 100M | 57M | 11M | -44M | -118M | 41M | -26M | -26M | -26M |
| Owner Earnings | -63M | -43M | 26M | 77M | 36M | 10.0M | -58M | -133M | 26M | -34M | -33M | -33M |
| CapEx | 2.9M | 10M | 3.3M | 2.5M | 4.9M | 13M | 7.2M | 1.2M | 1.6M | 1.4M | 516K | 516K |
| Maint. CapEx | 285K | 2.7M | 571K | 6.2M | 17M | 4.2M | 8.1M | 8.7M | 7.7M | 5.0M | 4.5M | 4.5M |
| Growth CapEx | 2.6M | 7.6M | 2.7M | 0 | 0 | 8.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 285K | 2.7M | 571K | 6.2M | 17M | 4.2M | 8.1M | 8.7M | 7.7M | 5.0M | 4.5M | 4.5M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 652K | 0 | 0 | 6.3M | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 19M | 0 | 0 | 1.2M | 0 | 0 | 2.2M | 8.2M | 2.5M | 2.3M | 1.2M | 1.2M |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% |
| Stock-Based Comp | 56M | 58M | 9.7M | 20M | 7.9M | 10.0M | 13M | 7.3M | 8.8M | 4.8M | 2.5M | 2.5M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||||||
| Net Debt | N/A | -147M | -53M | -209M | -217M | -91M | 189M | 203M | 112M | 59M | 182M | 182M |
| Cash & Equiv. | 220M | 153M | 56M | 210M | 259M | 348M | 230M | 129M | 134M | 91M | 57M | 57M |
| Long-Term Debt | N/A | 2.7M | 397K | 2.0M | 314K | 9.2M | 114M | 99M | 120M | 75M | 59M | 59M |
| Debt/Equity | N/A | 0.51 | 0.17 | 0.03 | 0.12 | 0.62 | 0.92 | 0.87 | 0.71 | 0.60 | 1.11 | 1.11 |
| Interest Coverage | -157.3 | 17.7 | 60.5 | 31.5 | 18.1 | 1.2 | 2.1 | -7.5 | -4.5 | -8.5 | -5.1 | -5.1 |
| Equity | -21M | 30M | 35M | 263M | 359M | 418M | 458M | 387M | 351M | 252M | 215M | 215M |
| Total Assets | N/A | 973M | 225M | 474M | 743M | 905M | 955M | 764M | 636M | 529M | 565M | 565M |
| Total Liabilities | N/A | 634M | 136M | 211M | 385M | 486M | 495M | 374M | 283M | 276M | 350M | 350M |
| Intangibles | N/A | 1.2M | 821K | 9.3M | 12M | 22M | 21M | 18M | 9.9M | 7.1M | 14M | 14M |
| Retained Earnings | 1.5M | -36M | 20M | 49M | 131M | 174M | 199M | 137M | 104M | 29M | -11M | -11M |
| Working Capital | N/A | 225M | 64M | 214M | 274M | 312M | 279M | 187M | 162M | 56M | 6.7M | 6.7M |
| Current Assets | N/A | 860M | 199M | 416M | 631M | 740M | 617M | 429M | 317M | 252M | 294M | 294M |
| Current Liabilities | N/A | 634M | 135M | 202M | 356M | 428M | 338M | 242M | 155M | 195M | 287M | 287M |
| Per Share Data | ||||||||||||
| EPS | -1.22 | -0.22 | 0.28 | 0.07 | 0.32 | 0.13 | 0.08 | -0.18 | -0.13 | -0.29 | -0.16 | -0.16 |
| Owner EPS | -1.26 | -0.78 | 0.29 | 0.33 | 0.14 | 0.04 | -0.21 | -0.55 | 0.11 | -0.13 | -0.13 | -0.13 |
| Book Value | -0.42 | 0.55 | 0.38 | 1.12 | 1.40 | 1.55 | 1.70 | 1.61 | 1.47 | 0.96 | 0.86 | 0.86 |
| Cash Flow/Share | -0.13 | 0.31 | 0.40 | 0.44 | 0.24 | 0.09 | -0.13 | -0.49 | 0.18 | -0.09 | -0.10 | -0.14 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 | N/A | N/A | 0.03 | N/A | N/A | N/A | 0.00 |
| Shares Out. | 50.2M | 55.1M | 91.3M | 235.8M | 257.1M | 269.7M | 270.3M | 240.2M | 238.6M | 261.1M | 250.4M | 250.4M |
| Valuation | ||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -30.9 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 5.8 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 4.8 |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -2.1% |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2B |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.95 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.95 |
Zepp Health Corp passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 17.3%.
Zepp Health Corp (ZEPP) has a 5-year average return on invested capital (ROIC) of -8.8%. This is below average and may indicate limited pricing power.
Zepp Health Corp (ZEPP) has a market capitalization of $1.2B. It is classified as a small-cap stock.
Zepp Health Corp (ZEPP) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.10%.
Zepp Health Corp (ZEPP) reported annual revenue of $259 million in its most recent fiscal year, based on SEC EDGAR filings.
Zepp Health Corp (ZEPP) has a net profit margin of -15.5%. The company is currently unprofitable.
Zepp Health Corp (ZEPP) generated $-26 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Zepp Health Corp (ZEPP) has a debt-to-equity ratio of 1.11. This indicates moderate leverage.
Zepp Health Corp (ZEPP) reported earnings per share (EPS) of $-0.16 in its most recent fiscal year.
Zepp Health Corp (ZEPP) has a return on equity (ROE) of -17.2%. A negative ROE may indicate losses or negative equity.
Zepp Health Corp (ZEPP) has a 5-year average gross margin of 17.3%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 11 years of financial data for Zepp Health Corp (ZEPP), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Zepp Health Corp (ZEPP) has a book value per share of $0.86, based on its most recent annual SEC filing.